What is ENTYVIO?
What is ENTYVIO?ENTYVIO (vedolizumab) is a medication used to treat inflammatory bowel disease (IBD). Specifically , ENTYVIO is used to treat adults with moderate to severe ulcerative colitis or Crohn's disease, two types of IBD that are characterized by chronic inflammation of the digestive tract.
How does ENTYVIO work?ENTYVIO works by selectively targeting a type of white blood cell called integrin alpha4beta7. This cell is involved in the inflammation process that causes IBD symptoms. By binding to integrin alpha4beta7, ENTYVIO blocks the white blood cells from entering the digestive tract, reducing inflammation and helping to alleviate symptoms.
How is ENTYVIO administered?ENTYVIO is administered through intravenous infusion, which means that it is given directly into a vein through a needle. The infusion is typically given by a healthcare professional in a hospital or clinic setting.
What are the side effects of ENTYVIO?Like all medications, ENTYVIO can cause side effects. Some common side effects include headache, nausea, and joint pain. More serious side effects can occur, such as allergic reactions, infections, and liver problems. It is important to discuss any potential side effects with a healthcare professional before beginning treatment with ENTYVIO.
How effective is ENTYVIO?Overall, ENTYVIO has been shown to be an effective treatment for both ulcerative colitis and Crohn's disease. Clinical trials have shown that ENTYVIO can reduce symptoms and improve quality of life for people with IBD. However, the effectiveness of the medication can vary from person to person, and it may take several weeks or months of treatment before significant improvements are seen.
How is the dosage of ENTYVIO determined?The dosage of ENTYVIO is determined by a healthcare professional based on factors such as the patient's weight, medical history, and the severity of their IBD symptoms. Typically, ENTYVIO is given as an initial dose followed by additional doses at weeks 2 and 6, and then every 8 weeks thereafter. Dosage adjustments may be made based on the patient's response to treatment and any side effects they experience.
Frequently Asked Questions about entyvio
Entyvio® is a brand of vedolizumab. This injection treats ulcerative colitis and Crohn's disease.
Serious infection
In very rare cases, Entyvio can lead to a viral infection in the brain. This is called progressive multifocal leukoencephalopathy (PML). People who already have a weak immune system are at higher risk of PML. For most people, the virus that causes this condition is nothing to worry about.
What is the most important information I should know about ENTYVIO? ENTYVIO may cause serious side effects, including: Infusion-related and serious allergic reactions. These reactions can happen while you are receiving ENTYVIO or several hours after treatment.
Entyvio (vedolizumab) is a biologic therapy approved for the treatment of ulcerative colitis and Crohn's disease. It works selectively in the gut to decrease inflammation and does not usually lead to system-wide immunosuppression.
Examples of long-term side effects that can happen with Entyvio include:
- serious infection, which may lead to sepsis (a serious, life threatening response to infection that can cause organ damage)
- liver problems, such as hepatitis (inflammation of the liver)
- certain cancers*
The most common side effects of ENTYVIO include: common cold, headache, joint pain, nausea, fever, infections of the nose and throat, tiredness, cough, bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, and pain in extremities. These are not all the possible side effects of ENTYVIO.
Long-term use of Entyvio was shown to be safe and effective in patients with moderate-to-severe ulcerative colitis and Crohn's disease through 5 years, according to interim results from the ongoing GEMINI open-label long-term safety study presented at the 12th Congress of the European Crohn's and Colitis Organization.
You may receive "killed-virus" vaccines such as a flu shot, polio vaccine, rabies vaccine, or hepatitis A vaccine. Ask your doctor before receiving any vaccine while you are being treated with Entyvio. Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.
Yes, Entyvio is meant to be used as a long-term treatment. How long you'll receive Entyvio depends depends on whether the drug is working to manage the symptoms of your condition. If you and your doctor determine that Entyvio is safe and effective for you, it's likely that you'll be given it long term.
You may see some symptom relief after your first dose of Entyvio. But it may take several weeks for you to be free of symptoms. If you don't have significantly reduced symptoms by week 14 of treatment, your doctor will likely have you stop taking Entyvio.